Medication info
Forend Plus D Tablets

Forend Plus D Tablets

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Trihydrate›91.37mg / 1 tabletCholecalciferol Concentrate Powder›53.33mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White to grayish-white oblong tablets
Packaging
4 tablets (4 tablets/PTP X 1)
Approval status
Active

MFDS item code 201203484 · Approved 2012.04.26 · Insurance code 671805250

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. Discontinuation should be considered after 3~5 years of treatment in patients at low risk of fracture. Patients who discontinue treatment should be periodically reassessed for fracture risk. Other beverages, foods, and medicines, including mineral water and barley tea, may reduce the absorption of alendronate (see “Drug Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce the absorption of alendronate in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it, and remain upright until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients who do not get enough calcium and vitamin D from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. One weekly dose of this medicine provides the equivalent of one week’s supply of daily vitamin D at 400 IU or 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Use in elderly patients (65 years and older): No dose adjustment is necessary. Use in patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance below 35 mL/min), because there is insufficient clinical experience.
Child dose
Children and adolescents (under 18 years): The safety and efficacy in children and adolescents have not been established.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in post-menopausal women and men.

How to take

Adult dose

Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. Discontinuation should be considered after 3~5 years of treatment in patients at low risk of fracture. Patients who discontinue treatment should be periodically reassessed for fracture risk. Other beverages, foods, and medicines, including mineral water and barley tea, may reduce the absorption of alendronate (see “Drug Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce the absorption of alendronate in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it, and remain upright until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients who do not get enough calcium and vitamin D from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. One weekly dose of this medicine provides the equivalent of one week’s supply of daily vitamin D at 400 IU or 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Use in elderly patients (65 years and older): No dose adjustment is necessary. Use in patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance below 35 mL/min), because there is insufficient clinical experience.

Child dose

Children and adolescents (under 18 years): The safety and efficacy in children and adolescents have not been established.

Precautions

This medication may irritate the gastrointestinal mucosa, potentially leading to esophageal problems such as esophagitis or esophageal ulcers. It is essential to take it with a sufficient amount of water and avoid lying down for at least 30 minutes after taking it. If symptoms of esophageal problems occur, discontinue use immediately and consult a doctor. This medication is not to be administered to patients with esophageal strictures or those who cannot remain upright for at least 30 minutes. It is also contraindicated in patients with hypocalcemia or lactose intolerance. Calcium supplementation may be required during use, and especially for those at high risk of vitamin D deficiency, vitamin D supplementation is recommended. Calcium supplements and antacids should not be taken simultaneously with this medication but at different times. Caution is needed when used with aspirin or non-steroidal anti-inflammatory drugs, as the risk of gastrointestinal adverse reactions may increase. This medication is not recommended for children, pregnant women, or patients with severe renal failure. Rarely, prolonged use may result in atypical fractures of the bone, so if pain persists, consult a doctor. Ensure to take this medication with sufficient water before meals and avoid lying down immediately after taking it. In the case of overdose, gastrointestinal irritation or symptoms of hypocalcemia may occur, so inform medical personnel immediately. Store this medication out of reach of children and do not transfer it to another container.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, indigestion, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal (bone, muscle or joint) pain, muscle cramps, headache, dizziness, taste disorders, rash, erythema, anastomotic ulcer, esophageal stricture, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, osteomyelitis, osteonecrosis of the jaw, joint swelling, low-energy fractures of the femoral neck and other bones, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, external auditory canal cholesteatoma, urticaria, angioedema, myalgia, fatigue, weakness, fever, hypocalcemia, peripheral edema, rhinitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a sealed container. Maintain the temperature between 1 degree and 30 degrees Celsius at room temperature and store it away from direct sunlight.

Appearance and packaging

Appearance

White to grayish-white oblong tablets

Package unit

4 tablets (4 tablets/PTP X 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.